Drug intelligence / Profile preview

angelica sinensis polysaccharide

Development stage
Preclinical
Lead developer
Jiangsu Administration of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intraperitoneal
01

Overview

Angelica sinensis polysaccharide (ASP) is a bioactive polysaccharide extracted from the root of the traditional Chinese medicinal plant *Angelica sinensis* (Dong Quai). It is being investigated for multiple therapeutic applications, including anemia and osteoarthritis. In the context of anemia of chronic kidney disease (CKD), ASP has been shown to correct anemia in preclinical models by stimulating the production of erythropoietin (EPO) in both the kidney and liver. [1] This is achieved by stabilizing the hypoxia-inducible factor 2-alpha (HIF-2α) protein and blocking inflammatory signaling pathways involving GATA2 and NF-κB. [1] ASP also improves systemic iron availability by suppressing the production of hepcidin. [1] For osteoarthritis, ASP demonstrates chondroprotective effects by reducing oxidative stress, improving mitochondrial metabolism, and promoting the synthesis of proteoglycans in cartilage. [7, 9] This mechanism involves the activation of the PPARγ/SOD2 pathway and increased expression of aggrecan and insulin-like growth factor 1 (IGF-1) and its receptor. [6, 9]

Other names
当归多糖Angelica sinensis polysaccharides
02

Targets

ASGPR (Asialoglycoprotein Receptor 1)

Beyond the preview

Go deeper on angelica sinensis polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on angelica sinensis polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call